Separation Of Micro-organism From Culture Media Patents (Class 435/261)
  • Patent number: 6544512
    Abstract: A biocontrol agent containing Phoma glomerata for suppressing development of fungal diseases on plants and methods of using this biocontrol agent in the suppression of fungal disease on plants are provided. The Phoma glomerata is preferably Phoma glomerata ATCC MYA-2373 that suppresses powdery mildew on plants.
    Type: Grant
    Filed: March 2, 2000
    Date of Patent: April 8, 2003
    Assignee: Rutgers, the State University of New Jersey
    Inventor: James F. White, Jr.
  • Patent number: 6524576
    Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: February 25, 2003
    Assignee: The Bio Balance Corporation
    Inventors: Mark Olshenitsky, Genadi Buchman
  • Patent number: 6514688
    Abstract: Biological materials in a mixture of substances are separated, detected or quantified using magnetic spherically shaped cross-linked polyvinyl alcohol (PVAL) polymer particles ranging in size from 1 to 10 &mgr;m. The particles containing a coupled ligand are used to bind a biological material in a mixture of substances, and the particles containing bound biological material are isolated from the mixture. The particles are prepared by dispersing a magnetic colloid containing a magnetic material such as a ferromagnetic or superparamagnetic substance in an aqueous solution of polyvinyl alcohol containing reactive hydroxyl groups, adding the resultant mixture to an organic phase containing a mixture of at least two emulsifiers, and adding a water-soluble cross-linking agent such as a dialdehyde that reacts with the hydroxyl groups of polyvinyl alcohol to form the polymer particles.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: February 4, 2003
    Assignee: chemagen Biopolymer-Technologie Aktiengesellschaft
    Inventor: Detlef Muller-Schulte
  • Patent number: 6503746
    Abstract: Polyaromatic hydrocarbons are found in contaminated soils and groundwater and are a large class of compounds for which treatment by bioremediation is sought. Accordingly, indigenous organisms that can degrade polyaromatic hydrocarbon are needed. Presented are strains of the Paenibacillus genus that degrade low molecule weight polyaromatic, and, in the presence of phenanthrene, high molecular weight polyaromatic hydrocarbons. These bacteria strains are unique among PAH-degrading bacterial strains because they form endospores and therefore can survive adverse environmental conditions. Among the strains presented are several from “P. naphthalenovorans”, a newly described species and also P. validus. Also presented are compositions for bioremediation comprising the bacterial strains of the invention and a method for isolating the strains and a method for using the strains for bioremediation.
    Type: Grant
    Filed: August 17, 1999
    Date of Patent: January 7, 2003
    Assignee: Rutgers, the State University
    Inventors: Lori Daane, Max M. Haggblom
  • Patent number: 6479239
    Abstract: A method for separating microorganisms, especially infectious agents, from a mixture by two dimensional centrifugation on the basis of sedimentation rate and isopycnic banding density, for sedimenting such microorganisms through zones of immobilized reagents to which they are resistant, for detecting banded particles by light scatter or fluorescence using nucleic acid specific dyes, and for recovering the banded particles in very small volumes for characterization by mass spectrometry of viral protein subunits and intact viral particles, and by fluorescence flow cytometric determination of both nucleic acid mass and the masses of fragments produced by restriction enzymes. The method is based on the discovery that individual microorganisms, such as bacterial and viral species, are each physically relatively homogeneous, and are distinguishable in their biophysical properties from other biological particles, and from non-biological particles found in nature.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: November 12, 2002
    Assignee: Large Scale Biology Corporation
    Inventors: Norman G. Anderson, N. Leigh Anderson
  • Patent number: 6451565
    Abstract: A process is provided for producing &ggr;-decalactone using Yarrowia lipolytica HR 145 (DSM 12397). The process includes preparing the product in a bioreactor by culturing the pure strain of Yarrowia lipolytica in a culture medium containing carbon compounds, nitrogen compounds, inorganic salts, trace elements, vitamins, etc. Other ingredients of the culture medium include glycerol, glucose, mannitol, citric acid, malt extract, yeast extract, casein hydrolysate, castor oil, cotton seed meal or corn steep liquor. Also sulphates, nitrates, chlorides, carbonates or phosphates of metals sodium, potassium magnesium, manganese, calcium, zinc, and mixtures thereof can be used in the culture medium. Further, a pure strain of Yarrowia lipolytica HR 145 (DSM 12397) is provided.
    Type: Grant
    Filed: April 20, 2001
    Date of Patent: September 17, 2002
    Assignee: Haarmann & Reimer GmbH
    Inventors: Jürgen Rabenhorst, Ian Gatfield
  • Patent number: 6423337
    Abstract: The present invention relates to a porous structure of prepared fungal cell wall components, whereby the cell wall material is derived from a fungi selected from the division Zygomycota, the fungal material in the form of a suspension is subjected to drying in such a way that the material obtains a porous structure, the structure has a liquid absorbing property which is at least 15 ml/g of 1% NaCl (aq) and it has a liquid transporting ability of water, at a density of 0.01 to 0.03 g/cm3, in a horizontal direction of at least 10 mm during the first minute of absorption and in a vertical direction of at least 5 mm during a first minute of absorption.
    Type: Grant
    Filed: October 11, 2000
    Date of Patent: July 23, 2002
    Assignee: Lizyx AB
    Inventor: Lars Edebo
  • Patent number: 6420165
    Abstract: A biologically pure culture of a microorganism is provided designated SH2A and deposited under ATCC Accession No. 55926, or a mutant derived therefrom. Further provided is a biologically pure culture of a microorganism designated SH2B and deposited under ATCC Accession No. 202050, or a mutant derived therefrom. A method of degrading an organic material such as sludge is carried out by treating the organic material with an effective, degrading amount of either SH2A or a mutant derived therefrom, or SH2B or a mutant derived therefrom. The microorganism designated SH2A or a mutant derived therefrom, or SH2B or a mutant derived therefrom, is grown by culturing the microorganism at a temperature and in a medium effective to promote growth of the microorganism.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: July 16, 2002
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Bernard I. Weinstein, David Figurski, Sadayori Hoshina, Koji Nakanishi
  • Patent number: 6410244
    Abstract: The invention relates to methods of preparing plasmid pools by growing colonies in discrete wells of a semi-solid or gelatinous medium. This method may facilitate colony collection, reduce colony overgrowth, reduce contamination by adventitious microorganisms, and increase the efficiency of plasmid screening techniques.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: June 25, 2002
    Assignee: Curis, Inc.
    Inventor: Hong Wu Xu
  • Patent number: 6395533
    Abstract: Microorganisms are recovered from soil by suspending a soil sample containing the microorganisms in a buffer solution comprising an organic acid of 3 or more carbon atoms, and then separating the microorganisms into supernatant of the suspension. Furthermore, the citrate buffer is a citric acid and a salt of citric acid. Also microorganisms are separated from the soil particles and recovered from the suspension by centrifugation or electrophoresis.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: May 28, 2002
    Assignee: Canon Kabushiki Kaisha
    Inventors: Masahiro Kawaguchi, Etsuko Sugawa, Akira Kuriyama
  • Patent number: 6379952
    Abstract: Azlactone-functional supports are used to provide cell selection from a mixture such as bone marrow or peripheral blood having a desired target cell population. An azlactone-functional support is derivatized by covalently coupling to the support a biologically active substance that binds the target cells. A mixture containing the target cells is contacted with the derivatized support to bind the target cells to the biologically active substance, and unbound remaining mixture is removed from the support. Bound cells may be eluted from the support to obtain purified target cells. Biologically active substances include antibodies, lectins, proteins, antigens and avidin. The biologically active substance may directly or indirectly bind cells in the mixture. Indirect binding may be through a second, intermediary biologically active substance that is bifunctional.
    Type: Grant
    Filed: February 1, 1999
    Date of Patent: April 30, 2002
    Assignee: 3M Innovative Properties Company
    Inventors: Jerald K. Rasmussen, Patrick L. Coleman
  • Patent number: 6372447
    Abstract: An apparatus and method are provided for preparing specimens of biological cells uniformly distributed over a substrate surface. The method comprises providing a suspension of biological cells in fluid, and then extracting biological target cells from the suspension to leave debris and contaminants behind. The extracted target cells are distributed over a substrate surface into a primary layer of cells coupled to the substrate surface with the remaining cells forming a secondary layer on top of the primary layer. The target cells forming the secondary layer are then removed to produce a substantially non-overlapping layer of target cells coupled to the substrate surface.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: April 16, 2002
    Assignee: Veracel Inc.
    Inventor: Ryan S. Raz
  • Publication number: 20020034817
    Abstract: Novel closed system methods and apparatus for the production and utilization of algae are disclosed. A substantially pure form of a desired strain of alga is obtained and cultivated (or isolated and grown). The desired species of alga is isolated from the contaminants and other algae and placed in the controlled environment where its growth is cultivated without contaminants. At desired points in time, a portion of the cultivated alga is removed, with the remainder serving as progenitor stock for growing more of the desired alga. The removed alga is processed and placed in product form.
    Type: Application
    Filed: October 5, 2001
    Publication date: March 21, 2002
    Inventors: Eric C. Henry, Kenneth L. Cordrey, Christopher A. Bakken, Craig L. Berkman
  • Patent number: 6352838
    Abstract: Manipulation of DNA molecules in solution has become an essential aspect of genetic analyses used for biomedical assays, the identification of hazardous bacterial agents, and in decoding the human genome. Currently, most of the steps involved in preparing a DNA sample for analysis are performed manually and are time, labor, and equipment intensive. These steps include extraction of the DNA from spores or cells, separation of the DNA from other particles and molecules in the solution (e.g. dust, smoke, cell/spore debris, and proteins), and separation of the DNA itself into strands of specific lengths. Dielectrophoresis (DEP), a phenomenon whereby polarizable particles move in response to a gradient in electric field, can be used to manipulate and separate DNA in an automated fashion, considerably reducing the time and expense involved in DNA analyses, as well as allowing for the miniaturization of DNA analysis instruments.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: March 5, 2002
    Assignee: The Regents of the Universtiy of California
    Inventors: Peter A. Krulevitch, Robin R. Miles, Xiao-Bo Wang, Raymond P. Mariella, Peter R. C. Gascoyne, Joseph W. Balch
  • Patent number: 6346421
    Abstract: A method for separating microorganisms, especially infectious agents, from a mixture by two dimensional centrifugation on the basis of sedimentation rate and isopycnic banding density, for sedimenting such microorganisms through zones of immobilized reagents to which they are resistant, for detecting banded particles by light scatter or fluorescence using nucleic acid specific dyes, and for recovering the banded particles in very small volumes for characterization by mass spectrometry of viral protein subunits and intact viral particles, and by fluorescence flow cytometric determination of both nucleic acid mass and the masses of fragments produced by restriction enzymes. The method is based on the discovery that individual microorganisms, such as bacterial and viral species, are each physically relatively homogeneous, and are distinguishable in their biophysical properties from other biological particles, and from non-biological particles found in nature.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: February 12, 2002
    Assignee: Large Scale Proteomics Corp.
    Inventors: Norman G. Anderson, N. Leigh Anderson
  • Patent number: 6346196
    Abstract: A slowly rotating separation chamber with an oscillating axial magnetic field gradient created by an alternating current solenoid superimposed on a steady radial gradient in a horizontal chamber is used as part of a flow-through multiunit colloidal magnetic affinity separation device including magnets. The field-gradient induced microscale particle motion, as well as particle resuspension by chamber rotation, significantly enhances particle-target contact without generating damaging shear forces. Chamber rotation also minimizes sedimentation of non-neutrally buoyant magnetic particles. The alternating current solenoid are a series of coils arranged along the axial flow direction, a single chamber is utilized as a flow-through multistage separation device, leading to a major increase in volume and reduced “down” times as compared to batch equipment.
    Type: Grant
    Filed: March 13, 2001
    Date of Patent: February 12, 2002
    Assignee: The Board of Governors for Higher Education State of Rhode Island Providence Plantations
    Inventor: Arijit Bose
  • Patent number: 6342230
    Abstract: The present invention pertains to materials and methods for preventing, or reducing the severity of, heartwater disease in animals. One aspect of the invention is a vaccine against heartwater comprising cultured inactivated Cowdria ruminantium rickettsiae mixed with a suitable adjuvant. The vaccine of the subject invention can be injected into an animal and, once injected, induces immune responses which protect the animal from severe heartwater when exposed to infection with Cowdria ruminantium rickettsiae. The invention further concerns methods of producing a vaccine for use against heartwater. The invention also concerns methods for inducing an immune response in animals, such as mammals, against heartwater by inoculating an animal with a vaccine composition of the present invention.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: January 29, 2002
    Assignee: University of Florida
    Inventors: Suman M. Mahan, Anthony F. Barbet, Michael J. Burridge, Gillian E. Smith
  • Patent number: 6340580
    Abstract: A method is provided for isolating and purifying PHA from microbial or plant biomass that contains PHA. The method includes the step of extracting PHA from the biomass using at least one solvent while simultaneously subjecting the biomass to a filtration process to remove cells. In a preferred embodiment of the method, an aqueous slurry of the biomass is directly extracted by diafiltration using an organic solvent. In a preferred diafiltration process, an aqueous slurry of microbial cells comprising PHA is recirculated through a filtration membrane, wherein the membrane has a pore size sufficiently small to reject individual cells or such aggregates of cells as may exist in the slurry.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: January 22, 2002
    Assignee: Metabolix, Inc.
    Inventor: Daniel Horowitz
  • Patent number: 6335191
    Abstract: An automated system and method is provided for cultivating bacteria in a fluid medium and thereafter selectively discharging the fluid medium, wherein an initial supply of the selected strain or strains of bacteria is combined with nutrients and water in a biogenerator in the presence of air to promote mixing and bacterial cultivation. The system and method utilize a vortex created by recirculation of the fluid medium to achieve aeration and mixing without substantial foaming. The system and method are particularly useful for supplying bacteria to control grease accumulation in restaurant grease traps. The system and method use a biogeneration chamber which has a cylindrical sidewall and surface on the inner side. Further, the chamber has a top and a conical bottom. The top has inlet ports and a vent port. There is also a outlet port in the conical bottom.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: January 1, 2002
    Assignee: NCH Corporation
    Inventors: Dale Vilmer Kiplinger, Judith Gayle Pruitt, Jose Eduardo Evaro, Robert Clarence Pearce, III
  • Patent number: 6331431
    Abstract: A high throughput device is provided for simultaneously isolating periplasmic fractions from multiple samples of host cells. The device can be formatted to operate in a series. A method for simultaneously isolating multiple periplasmic fractions is also provided. The method includes (a) providing a high throughput device for isolating periplasmic fractions from multiple samples of host cells having an outer membrane via attaching a removable sample chamber having a membrane chamber wall to a vacuum chamber and applying a vacuum thereto (b) removing media with the vacuum and (c) removing the outer membrane of the host cells (d) attaching a collection chamber to the vacuum chamber and applying a vacuum thereto in order to carry out a collection of the periplasmic fractions that pass through the membrane of the chamber wall from the host cells.
    Type: Grant
    Filed: November 28, 1995
    Date of Patent: December 18, 2001
    Assignee: Ixsys, Inc.
    Inventors: Scott M. Glaser, William D. Huse, William P. MacConnell
  • Publication number: 20010051353
    Abstract: A comprehensive and integrated system for monitoring (identifying, tracking and analyzing) an individual patient's malignancy through the duration of a malignancy as to a specific patient is provided. The method of the present invention allows for initial identification of a malignancy, identification of malignancy-specific cellular or secretal markers, identification of cellular or secreted markers indicative of complications, study of the invasiveness and aggressiveness of the malignancy, study of the growth rate of the malignancy, study of the effect of therapies on the malignancy as compared to control cells of the same patient (chemosensitivity versus toxicity) and the identification of a therapeutic index (i.e., the ratio of chemosensitivity:toxicity), study of tumor morphology and study of histological, cytochemical and immunocytochemical markers.
    Type: Application
    Filed: November 10, 1998
    Publication date: December 13, 2001
    Inventor: PAUL L. KORNBLITH
  • Patent number: 6287800
    Abstract: A new method of producing a mixture of gibberellins which is predominantly GA4 and GA7 but also contains GA3 has the steps of providing a seed of Gibberella fujikuroi Strain LTB-1027 or mutants derived therefrom, inoculating the seed into a culture medium rich in carbohydrate and relatively low in nitrogen, incubating the culture for at least four days, separating the Gibberella fujikuroi Strain LTB-1027 from the culture broth, and extracting the gibberellins to produce a gibberellin mixture which is at least 50% GA4 and GA7. The method produces a gibberellin mixture in which the combined titer of GA4 and GA7 exceeds 800 mg/liter. The production method also produces a gibberellin mixture with approximately equal titers of gibberellins GA4 and GA7. A variation of the method produces a gibberellin mixture which contains over 40% GA4.
    Type: Grant
    Filed: August 23, 2000
    Date of Patent: September 11, 2001
    Inventors: Jorge L. Gallazzo, May D. Lee
  • Patent number: 6268119
    Abstract: A cell separation method comprising steps of introducing a cell-containing fluid containing cells to be recovered and cells to be removed, into a cell-capturing means capable of substantially capturing the cells to be recovered and substantially permitting passage therethrough of cells to be removed; taking out the resulting fluid containing the cells to be removed, from the cell-capturing means; and then introducing a liquid with a viscosity of not more than 500 mPa·s and not less than 5 mPa·s into the cell-capturing means to recover therefrom the cells to be recovered which have been captured by the cell-capturing means.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: July 31, 2001
    Assignee: Asahi Medical Co., Ltd.
    Inventors: Masaya Sumita, Shuji Terashima
  • Patent number: 6242229
    Abstract: Cosmetic/pharmaceutical compositions, suitable for cosmetic applications and/or for treating a wide variety of mammalian disorders or disease states, comprise an effective active principle amount of a clarified and stabilized culture medium for at least one non-photosynthetic filamentous bacterium, advantageously belonging to the genera Beggiatoa, Vitreoscilla, Flexithrix or Leucothrix, formulated into a cosmetically/pharmaceutically acceptable vehicle, diluent or carrier therefor.
    Type: Grant
    Filed: May 5, 1998
    Date of Patent: June 5, 2001
    Assignee: Societe L'Oreal S.A.
    Inventors: Nathalie Pineau, Richard Martin, Lionel Breton, Lucien Aubert
  • Patent number: 6214601
    Abstract: A method for inhibiting the growth of microorganisms in an aqueous medium comprises contacting the aqueous medium with a permeable body comprising material which interacts with the microorganisms. Such interaction involves a change in the chemical structure of the material resulting from the action of one or more of the microorganisms. The permeable body may take the form of a permeable bag containing plant fibers and may be used for the treatment of photoprocessor wash waters.
    Type: Grant
    Filed: June 26, 1997
    Date of Patent: April 10, 2001
    Assignee: Eastman Kodak Company
    Inventors: Gregory N. Batts, Christopher P. Moore, Karen Leeming
  • Patent number: 6197571
    Abstract: The present invention relates to preparation of protein polysaccharide 0041 obtained by extracting a dried product of cultured mycelia of Agaricus blazei Murrill 0041 with hot water, and protein polysaccharide 0041 shows immunopotentiating antitumor activity when administered, so that it is useful as an antitumor agent against various tumors, and as an immunopotentiating substance against other diseases.
    Type: Grant
    Filed: December 3, 1998
    Date of Patent: March 6, 2001
    Assignee: Agaricus Laboratories Co., Ltd.
    Inventors: Manabu Hikichi, Shigenobu Okubo, Eiji Hiroe
  • Patent number: 6190903
    Abstract: A biologically pure culture of a microorganism is provided designated SH2A and deposited under ATCC Accession No. 55926, or a mutant derived therefrom. Further provided is a biologically pure culture of a microorganism designated SH2B and deposited under ATCC Accession No. 202050, or a mutant derived therefrom. A method of degrading an organic material is carried out by treating the organic material with an effective, degrading amount of either SH2A or a mutant derived therefrom, or SH2B or a mutant derived therefrom. The microorganism designated SH2A or a mutant derived therefrom, or SH2B or a mutant derived therefrom, is grown by culturing the microorganism at a temperature and in a medium effective to promote growth of the microorganism.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: February 20, 2001
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: I. Bernard Weinstein, David Figurski, Sadayori Hoshina, Koji Nakanishi
  • Patent number: 6184011
    Abstract: A method of releasing particulates from a solid matrix is provided. The method is effected adding to the solid matrix a degrading enzyme capable of degrading the solid matrix, to thereby release the particulates from the solid matrix.
    Type: Grant
    Filed: March 22, 1999
    Date of Patent: February 6, 2001
    Assignees: CBD Technologies, LTD, Yissum R&D Company of the Hebrew University
    Inventors: Daniel L. Siegel, Oded Shoseyov
  • Patent number: 6184027
    Abstract: Catalytically inactive murein binding enzyme diagnostic reagents and methods and kits for detecting eubacteria and fungus in biological samples.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: February 6, 2001
    Assignees: Anomeric, Inc., Board of Supervisors Louisiana State University
    Inventors: Roger A. Laine, Wai Chun.Jennifer Lo
  • Patent number: 6168949
    Abstract: The invention relates to an apparatus for the aerobic multiplication of micro-organisms. A tank with a conical bottom shape holds the fermentation broth and a circulating pump outside the tank circulates the fermentation broth from the bottom of the tank to the top. A heat exchanger maintains the desired process temperature. In accordance with the invention, the apparatus includes at least one atomizing nozzle contained within a vortex chamber for the fine atomization of the fermentation broth and for the mixing with process gas in the top of the tank above the fermentation broth. The fermentation broth in the lower portion of the tank is at a quiescent state without mechanical agitation.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: January 2, 2001
    Inventor: Karl Rubenberger
  • Patent number: 6140123
    Abstract: A method is provided for preconditioning and cryopreservation of cells harvested from a donor. Cells are suspended in a cell conditioning and cryopreservation medium containing a cryopreservative such as Dimethyl Sulfoxide (DMSO) and the suspension is incubated for a period of at least ten minutes and the cells are frozen. The medium includes adenosine, a calcium channel blocker, and a cell nutrient matrix comprising a sufficient amount of cell nutrients to sustain the metabolic needs of the cells during incubation without producing detectable levels of lactate or substantially depleting the nutrient substrates to maintain viability of the harvested cells. In some embodiments, a cryopreservative is added step-wise before the cell suspension is frozen and removed step-wise after the cell suspension is thawed.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: October 31, 2000
    Assignee: Cedars-Sinai Medical Center
    Inventors: Achilles A. Demetriou, Andreas Kamlot, Jacek Rozga
  • Patent number: 6126835
    Abstract: Provided is a magnetic separation device comprising a container having one or more outer surfaces; at least one magnetic sheet; and a physical coupler that is used to detachably secure the container to the magnetic sheet.
    Type: Grant
    Filed: February 1, 1999
    Date of Patent: October 3, 2000
    Assignee: BioCrystal Ltd.
    Inventors: Emilio Barbera-Guillem, Marlin O. Thurston
  • Patent number: 6121033
    Abstract: Degradable polyesters useful in packaging, packing, agricultural, biomedical, and other applications are made by reacting amine-protected glutamic acid with diols or epoxy compounds. The polyesters include a thermoplastic main chain aliphatic polyester, a thermoset heterochain polyester and a thermoset heterochain aromatic polyester. Each of these polyesters can be hydrolyzed into monomers using a biological catalyst such as the enzyme lipase. The thermoplastic main chain aliphatic polyester and the thermoset heterochain polyester can be degraded to respiratory gases and biomass with a mixed culture of Rhizopus chinesis, Rhizopus delemar, Penecillium pinophilum, Aspergillus niger and Pseudomonas aeruginosa microorganisms. This mixed culture of microorganisms can also be used to degrade other polyesters containing hydrolyzable backbone polyesters.
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: September 19, 2000
    Assignee: The Board of Regents of the University of Nebraska
    Inventors: Raef M. Tadros, Delmar C. Timm
  • Patent number: 6110380
    Abstract: Provided is a magnetic separation device comprising a container having one or more outer surfaces; at least one flexible magnetic sheet; and a non-permanent adhesive that is used to detachably secure an outer surface of the container to a flexible magnetic sheet.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: August 29, 2000
    Assignee: BioCrystal Ltd.
    Inventor: Emilio Barbera-Guillem
  • Patent number: 6103225
    Abstract: Disclosed is a process for growing the microflora Thraustochytrium, Schizochytrium, and mixtures thereof, which includes the growing of the microflora in fermentation medium containing non-chloride containing sodium salts, in particular sodium sulfate. In a preferred embodiment of the present invention, the process produces microflora having a cell aggregate size useful for the production of food products for use in aquaculture. Further disclosed is a food product which includes Thraustochytrium, Schizochytrium, and mixtures thereof, and a component selected from flaxseed, rapeseed, soybean and avocado meal. Such a food product includes a balance of long chain and short chain omega-3 highly unsaturated fatty acids. The lipids containing these fatty acids can also be extracted and used in nutritional, pharmaceutical and industrial applications.
    Type: Grant
    Filed: March 15, 1999
    Date of Patent: August 15, 2000
    Assignee: OmegaTech, Inc.
    Inventor: William R. Barclay
  • Patent number: 6100043
    Abstract: Cloning systems useful for the isolation of recombinant nucleic acid are disclosed in which the recombination of cloning-system nucleic acid and foreign nucleic acid is linked to the expression of a moiety on the surface of a host organism, the moiety being a first member of a binding pair. When recombination occurs between the nucleic acid and the foreign nucleic acid, the moiety is expressed on the surface of the host organism. The isolation of recombinant nucleic acid is then performed by attaching a second member of the binding pair to a solid support and contacting the host organism with the support. When the first member of the binding pair is expressed on the surface of the host organism, the host organism binds to the second member of the binding pair attached to the solid support, thereby selectively isolating those organisms.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: August 8, 2000
    Assignee: The Perkin-Elmer Corporation
    Inventors: John A. Bridgham, John Brandis, John Leong, Paul D. Hoeprich, Jr., Charles L. Sloan, Roger A. O'Neill
  • Patent number: 6046022
    Abstract: Methods and compositions are disclosed which comprise red rice fermentation products, that can be used as natural dietary supplements and/or medicaments for the treatment or prevention of hyperlipidemia and associated disorders and symptoms, such as cardiovascular diseases, cerebrovascular diseases, diabetes, hypertension, obesity, asthenic breathing, chronic headache, chest pain and tightness, limb swelling and distention, loss of appetite and excess expectoration. The methods and compositions are effective in lowering both the serum cholesterol and serum triglyceride levels in humans, and can be used for maintaining cardiovascular health. The invention also encompasses particular Monascus strains that yield fermentation products with the desired biological activities.
    Type: Grant
    Filed: November 6, 1997
    Date of Patent: April 4, 2000
    Assignee: Peking University
    Inventors: Mao Liang Zhang, Chi-Xiu Peng, Yu-Fang Zhou
  • Patent number: 6020150
    Abstract: A method for detecting the presence or absence of microorganisms belonging to the group which consists of bacteria and yeasts in a liquid sample (5) of a biological material. The method comprises placing the liquid sample (5) in a centrifuge tube (6a, 6b) above a gelled system (10) comprising at least (a) a first so-called development phase (1), i.e. a gel comprising a microorganism culture medium and a reagent for inducing a detectable optical measurement change in the presence of microorganisms, said gel being an intimate mixture of water and water-absorbing polymeric particles that have swelled in such a way that, in said intimate mixture, said polymeric particles have (.alpha.) a dry weight concentration of 0.05-0.2 g/ml, and (.beta.) a swollen-state diameter of 90-320 .mu.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: February 1, 2000
    Assignee: Diffusion Bacteriologie Du Var
    Inventors: Genevieve Contant-Pussard, Fran.cedilla.oise Boisard-Beaupere, Jean-Luc Martinoli, Alain Rousseau
  • Patent number: 6008040
    Abstract: A process and device are provided for achieving cascade flow to achieve rapid separations of target components from fluid mixtures is provided. The devices of the invention have a cascading flow channel. The separation processes of the invention may include singly or in combination, the step of adjusting the total voids volume in all elements employed in the devices of the invention to be equal to or less than 6% of the total volume of fluid that is to be processed. A single separation process or a combination of separation processes may be used where the fluid mixture is whole blood, whole blood that is diluted or is in some other way treated, concentrated, divided into two or more streams, or augmented with blood or blood components, cellular materials such as proteins, antibodies, enzymes and fractions thereof, and nuclear materials such as DNA, RNA and their fragments.
    Type: Grant
    Filed: July 5, 1996
    Date of Patent: December 28, 1999
    Assignee: Synosys, Inc.
    Inventor: Rajiv V. Datar
  • Patent number: 6004766
    Abstract: A method is provided for the detection of low levels of a microorganism in a sample in the presence of competing microflora, comprising the steps of: (a) exposing the sample to a solid support to which are adsorbed antibodies specific for said microorganism; (b) washing the solid support to remove unbound material; (c) combining the solid support with sterile nutrient broth which permits replication of said microorganism; (d) incubating the solid support with said nutrient broth at a temperature and for a time sufficient to allow said microorganism to replicate and be recaptured by said antibodies on said solid support; (e) releasing the bound microorganism from the solid support into a solution; and (f)assaying the solution for the microorganism. A kit for performing the assay also is provided.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: December 21, 1999
    Assignee: Biotechnology Australia Pty Limited
    Inventors: Vincent H. Atrache, Megan Ash, Ca Van Huynh
  • Patent number: 5968504
    Abstract: The present invention relates to biological control of plant diseases and concerns new Gliocladium catenulatum fungi and their use for controlling fungal infections in plants. The invention concerns also compositions comprising new strains of Gliocladium catenulatum and their use to said purpose.
    Type: Grant
    Filed: July 14, 1997
    Date of Patent: October 19, 1999
    Assignee: Kemira Agro Oy
    Inventors: Risto Tapio Tahvonen, Milja Tuulikki Keskinen, Marja-Leena Lahdenpera, Pekka Tapani Seiskari, Esa Petri Teperi, Ulla Anita Tuominen, Hanna Helena Avikainen
  • Patent number: 5962286
    Abstract: Strains of Aureobasidium pullulans (de bary) Arnaud can be used for the commercial production of gluconic acid by fermentation in aqueous liquid containing sugar, which in continuous culture from glucose form greater than or equal to 90% and greater than or equal to 90% molar selectivity. The process is conducted with an Fe and Mn optimized medium with a nitrogen-independent (N-independent) ion concentration. The iron (Fe) concentration with 3 g/l NH.sub.4 Cl is greater than or equal to 0.5 mM, and the manganese (Mn) concentration with 3 g/l NH.sub.4 Cl is greater than or equal to about 0.5 mM manganese (Mn). The pH is regulated between about 4.5 and about 8, in particular at 6.5-7, and the temperature between 24 and 32.degree. C., in particular at 29-30.degree. C. Particularly successful strains are Aureobasidium pullulans (de bary) Arnaud with the registration numbers DSM 7085, DSM 7086, DSM 7087, and DSM 7088.
    Type: Grant
    Filed: January 17, 1997
    Date of Patent: October 5, 1999
    Inventors: Savas Anastassiadis, Alexander Aivasidis, Christian Wandrey
  • Patent number: 5935841
    Abstract: Filamentous microorganisms of improved properties, for example growth rate, may be obtained by culturing a sample of desired morphology until a substantial proportion of the culture diverges from that morphology, selecting an organism from the culture at that stage which exhibits the desired morphology and repeating the process with the selected microorganism. Furthermore, an isolated Fusarium graminearum having all of the characteristics of IMI 366464 and also possessing a greater morphological stability and growth rate than Fusarium graminearium strain IMI 145,425 is disclosed.
    Type: Grant
    Filed: August 9, 1996
    Date of Patent: August 10, 1999
    Assignee: Zeneca Limited
    Inventors: Anthony Peter Joseph Trinci, Geoffrey David Robson, Marilyn Gail Wiebe, Thomas William Naylor, Trevor Williamson
  • Patent number: 5935842
    Abstract: A method for the high yield, agricultural production of Enteromorpha clathrata involving repeated steps of supplying brackish or seawater to a pond containing Enteromorpha clathrata.
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: August 10, 1999
    Assignee: Desert Energy Research, Inc.
    Inventor: Benjamin Moll
  • Patent number: 5929109
    Abstract: The present invention relates to an agent for enhancing and stabilizing the activity of Bifidus factor, containing at least one member selected from the group consisting of ascorbic acid, hyposulfurous acid and acetic anhydride as the effective ingredient, and by preparing the agent singly or in combination with Bifidus factor as a food and drink type or as a composition of pharmaceutical type, intestinal microflora can be ameliorated. The agent can be used as a selective medium for assaying the number of bifidobacteria.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: July 27, 1999
    Assignee: Meiji Milk Products Company Limited
    Inventors: Hiroharu Mori, Kakuhei Isawa, Tsutomu Kaneko
  • Patent number: 5916743
    Abstract: A method combining the techniques of immunoaffinity separation and continuous flow centrifugal separation is provided for selective separation of a nucleated heterogeneous cell population from a heterogeneous cell mixture. The heterogeneous cell mixture is intimately contacted to promote binding thereto by particles having attached a substance that actively binds to a specific desired type of cell out of the cell mixture. The particles are selected so that the sedimentation velocity of the particle/cell conjugate differs sufficiently from those of other cells in the cell mixture to allow its separation by means of a continuous flow cell separator.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 29, 1999
    Assignee: Baxter International Inc.
    Inventors: William C. Lake, Richard Giesler, Dennis Van Epps, John R. Chapman, Jeffrey A. Martinson, Dale R. Ellis, Frederick Aono, Daniel F. Bischof
  • Patent number: 5905038
    Abstract: A method and apparatus for filtering microorganisms from a sample and culturing the microorganisms employs a membrane filter (3) in a filter holder (10) in which holder the membrane filter is supported on an absorbent support (26) which is maintained in an expansible compressed state against the membrane filter so that any expansion of the membrane filter when wetted by a sample does not cause bubbling of the membrane filter away from its support entrapping air bubbles and so preventing supply of nutrient from culture medium supplied to the support from reaching the microorganisms on the membrane filter.
    Type: Grant
    Filed: November 24, 1997
    Date of Patent: May 18, 1999
    Assignee: Severn Trent Water Limited
    Inventor: Adrian Parton
  • Patent number: 5900374
    Abstract: The invention concerns a cell culture harvesting device consisting of a scraper head with a blade and a guide strip, the scraper head and the guide strip being connected with one another only by magnetic attraction. The magnetic attraction is achieved by the fact that one of the ends of the scraper head and the guide strip which are turned toward one another have a magnet and the other has either a magnet or a material which can be magnetized by the magnet of the respective counterpart. In this way, the scraper head and the guide strip can be moved synchronously and in parallel at a distance from one another. This has the advantage that the scraper head can be placed into the cell culture vessel before a cell culture is started and can be sterilized together with it thereby eliminating the risk of contamination due to a cell culture harvesting device later being placed into the cell culture vessel.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: May 4, 1999
    Assignee: Heraeus Instruments GmbH & Co. KG
    Inventor: Hans Otto-Nagels
  • Patent number: 5891707
    Abstract: Described is a system for efficiently producing live Enterocytozoon bieneusi (E. bieneusi) organisms using laboratory animals, preferably Mongolian gerbils. Some important steps are: providing at least one breeding pair; administering to each of such breeding pair a sufficient antibiotic in sufficient dosage to destroy essentially all parasites which might be passed to offspring, especially Trichomonas; permitting such breeding pair to produce and rear offspring as production animals; preventing breeding by the production animals by separating males from females in separate cages; immune-suppressing each production animal sufficiently to permit propagation of live E. bieneusi organisms; infecting each production animal with love E. bieneusi organisms administered in an amount sufficient for such organisms to propagate but insufficient to kill the production animal; and, during a production period following such infecting, collecting the feces of each production animal.
    Type: Grant
    Filed: June 16, 1997
    Date of Patent: April 6, 1999
    Inventors: Kenna Diane Swabby, Allen R. Cahill
  • Patent number: 5882916
    Abstract: The instant invention is a decontaminating process for reducing the surface tension of a biofilm allowing for the removal of the biofilm and control of underlying bacteria. A solution consists of saponin and a soft acid such as food grade sodium lactate. The saponin acts as a foaming agent providing surface tension reduction capable of loosening the biofilm. The solution is preferably applied by a mechanical device providing an efficient coating of the surface to be treated allowing a reduced amount of the lactate acid to be used allowing the acid to make contact with the bacteria while stripping away of the biofilm is made possible.
    Type: Grant
    Filed: February 15, 1996
    Date of Patent: March 16, 1999
    Assignee: Nouveau Technolgies, Inc.
    Inventor: Jack G. Wiersma